Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease
Links shared publicly online about this topic.
- 732total visits
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease
View full resource at medicalnewstoday.com
Tags: Diabetes, Kidney Health, Urinary System, Kidney Disease, End-Stage Renal Disease, Pharma, Nephrology, Chronic Kidney Disease
Most Recently Shared on November 13, 2010 at 8:04 am By:
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Diseas... http://bit.ly/dgOqpD
Also Shared By:
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on November 12, 2010 at 8:34 pm By:
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With… http://goo.gl/fb/WWHFj
Reata to present bardoxolone methyl Phase 2b clinical trial data for CKD, type 2 diabetes at ASN Conference
news-medical.net — “Reata Pharmaceuticals today announced that the company will present data on the primary endpoint from a pivotal Phase 2b clinical trial of bardoxolone methyl in patients with chronic kidney disease (CKD) and type 2 diabetes. The data will be presented in a late-breaking oral presentation at the American Society of Nephrology (ASN) Renal Week Conference to be held November 16-21, 2010, in Denver, Colorado.” View full resource at news-medical.net
Most Recently Shared on November 12, 2010 at 7:59 am By:
Reata to present bardoxolone methyl Phase 2b clinical trial data for CKD, type 2 diabetes at ASN Conference: Rea... http://bit.ly/bIR6WV
Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease - Drugs.com MedNews
drugs.com — “Late-Breaking Clinical Data Presentation at American Society of Nephrology Renal Week Conference IRVING, Texas, Reata Pharmaceuticals today announced that the c” View full resource at drugs.com
Most Recently Shared on November 11, 2010 at 10:04 pm By:
Drugs and Devices OW OW Health
Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney ... http://bit.ly/aRP5bR #drug
Advertisement
MNT Clinical Trials
@mnt_clinical
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease http://mnt.to/3Mvr
1 year ago...